Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AEM1 is an inhibitor of deregulated NRF2 transcriptional activity in cancer. AEM1 acts by broadly decreasing the expression of NRF2 controlled genes, sensitizing A549 cells to various chemotherapeutic agents, and inhibiting the growth of A549 cells in vitro and in vivo.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 84.00 | |
25 mg | In stock | $ 178.00 | |
50 mg | In stock | $ 313.00 | |
100 mg | In stock | $ 537.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 81.00 |
Description | AEM1 is an inhibitor of deregulated NRF2 transcriptional activity in cancer. AEM1 acts by broadly decreasing the expression of NRF2 controlled genes, sensitizing A549 cells to various chemotherapeutic agents, and inhibiting the growth of A549 cells in vitro and in vivo. |
Molecular Weight | 379.41 |
Formula | C20H14FN3O2S |
CAS No. | 1030123-90-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (79.07 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AEM1 1030123-90-0 Immunology/Inflammation Nrf2 AEM-1 inhibit Inhibitor Keap1-Nrf2 AEM 1 inhibitor